Seven Eight Capital, LP Ptc Therapeutics, Inc. Transaction History

Seven Eight Capital, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$24.69 - $40.12 $994,439 - $1.62 Million	-40,277 Reduced 68.62%	18,415 $563,000
Q1 2024 May 13, 2024	BUY	$24.15 - $31.95 $846,578 - $1.12 Million	35,055 Added 148.31%	58,692 $1.71 Million
Q4 2023 Feb 13, 2024	SELL	$18.07 - $29.37 $742,405 - $1.21 Million	-41,085 Reduced 63.48%	23,637 $651,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $1.45 Million - $2.72 Million	64,722 New	64,722 $1.45 Million
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $206,948 - $266,288	4,945 New	4,945 $248,000
Q1 2020 May 14, 2020	SELL	$32.37 - $59.36 $1.08 Million - $1.98 Million	-33,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $1.07 Million - $1.67 Million	33,300 New	33,300 $1.6 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $2 Million - $3.11 Million	-66,889 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$33.9 - $47.77 $2.27 Million - $3.2 Million	66,889 New	66,889 $3.14 Million
Q2 2018 Aug 07, 2018	SELL	$25.7 - $47.88 $205,600 - $383,040	-8,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$17.46 - $32.59 $139,680 - $260,720	8,000 New	8,000 $216,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.